WARNER C. GREENE, M.D., PH.D.
Osteopathic Medicine at Owens St, San Francisco, CA

License number

California G77830

Personal information

See more information about WARNER C. GREENE at radaris.com

Name

Address

Phone

Warner Greene, age 75

2270 Skyfarm Dr, Hillsborough, CA 94010

(650) 571-1331

Warner C Greene, age 75

25 Brooke Ct, Burlingame, CA 94010

(650) 571-1331
(650) 571-5633

Warner G Greene, age 75

19441 Romar St, Northridge, CA 91324

(818) 886-2955

Professional information

Director At Gladstone Institutes, Professor At Ucsf

Position:

Director, Gladstone Institute of Virology and Immunology at The J. David Gladstone Institutes, Professor of Medicine, Microbiology and Immunology at University of California, San Francisco, Co-Director at UCSF-GIVI Center for AIDS Research, Executive Chairman at Accordia Global Health Foundation

Location:

San Francisco Bay Area

Industry:

Research

Work:

The J. David Gladstone Institutes since 1992 - Director, Gladstone Institute of Virology and Immunology University of California, San Francisco since 1992 - Professor of Medicine, Microbiology and Immunology UCSF-GIVI Center for AIDS Research since 1994 - Co-Director Accordia Global Health Foundation since 1994 - Executive Chairman Accordia Global Health Foundation 2007 - 2013 - President Duke University 1987 - 1992 - Professor of Medicine, Investigator Howard Hughes Medical Institute National Cancer Institute 1983 - 1986 - Senior Investigator, Metabolism Branch National Cancer Institute 1979 - 1983 - Investigator, Metabolism Branch Massachusetts General Hospital 1978 - 1979 - Resident Massachusetts General Hospital 1977 - 1978 - Internship

Education:

Washington University in St. Louis School of Medicine 1971 - 1977
MD, PhD, Medical Scientist Training Program Stanford University 1967 - 1971
BA, 1971

Interests:

Research Science, Mentoring, Global Health, Golf

Honor & Awards:

Honors Program in Biology, Stanford University, 1970-1971 California Heart Assocation Research Fellowship Award, 1970 Sigma Xi, 1976 St. Louis Internists' Prize in Medicine, 1977 Alpha Omega Alpha, 1977 Am. Federation for Clinical Research, 1979 Am. Association of Immunologists, 1980 Am. College of Physicians, 1981 Diplomate, American Board of Internal Medicine, 1981 Diplomate, American Board of Allergy and Immunology, 1983 Washington Academy of Sciences Award in Biological Sciences, 1984 Am. Society for Clinical Investigation, 1985 Outstanding Investigator Award, American Federation for Clinical Research, 1987 Young Investigator Award, American Rheumatism Association, 1988 Fellow, American Rheumatism Association, 1988 Kroc Visiting Professor of Rheumatology, UCLA, 1989 Association of American Physicians, 1990 100 Most Cited Scientists, Institute for Scientific Information Vice President, American Society for Clinical Investigation, 1993-1994

Dr. Warner C Greene, San Francisco CA - MD (Doctor of Medicine)

Specialties:

Internal Medicine, Allergy & Immunology

Address:

1650 Owens St, San Francisco 94158
(415) 734-4805 (Phone), (415) 355-0153 (Fax)

Certifications:

Allergy & Immunology, 1983, Internal Medicine, 1981

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Washington Center / School of Medicine
Graduated: 1977
Massachusetts General Hospital
Natl Inst Hlth

Compositions And Methods For Delivery Of A Molecule Into A Cell

US Patent:

6664040, Dec 16, 2003

Filed:

Apr 20, 2001

Appl. No.:

09/839329

Inventors:

Michael P. Sherman - San Francisco CA
Warner C. Greene - San Francisco CA
Carlos M.C. de Noronha - San Francisco CA
Ulrich Schubert - Bethesda MA
Peter Henklein - Berlin, GB

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

C12Q 170

US Classification:

435 5, 435 29, 435 41, 435325, 530350, 530300, 530395

Abstract:

Provided is a composition comprising a Vpr polypeptide conjugated to a therapeutic molecule. Preferably, the Vpr comprises synthetic Vpr. The therapeutic molecule can comprise any molecule capable of being conjugated to Vpr or a fragment thereof, including a polypeptide, a polynucleotide, and/or a toxin. The invention additionally provides a method for delivering a molecule into a cell. The method comprises contacting the cell with a conjugate comprising a Vpr polypeptide conjugated to the molecule. The invention further provides a method for modulating the expression of a transgene in a cell, a method for killing a target cell population in a subject, a method for increasing the sensitivity of cells to radiation therapy, and a method for inhibiting cell proliferation.

Methods Of Identifying Agents For Inhibiting Lentivirus Replication

US Patent:

7108988, Sep 19, 2006

Filed:

Oct 30, 2002

Appl. No.:

10/285263

Inventors:

Michael Sherman - San Francisco CA, US
Warner Greene - San Francisco CA, US
Ulrich Schubert - Hamburg, DE
Victor Wray - Braunschweig, DE
Uwe Tessmer - Hamburg, DE
Peter Henklein - Berlin, DE
Karsten Bruns - Hamburg, DE

Assignee:

The J. David Gladstone Institutes - San Francisco CA

International Classification:

C12Q 1/70

US Classification:

435 71, 435 5, 435 697, 436501

Abstract:

The present invention provides screening methods for identifying a compound that induces loss of the lentiviral protein Vpr; screening methods for identifying compounds that inhibit the peptidyl-prolyl cis/trans isomerase (PPIase) activity of a protein that catalyzes cis-trans isomerization of cis-peptidylprolyl bonds in Vpr; and compounds identified by the screening methods. The compounds are useful for treating a lentiviral infection. The present invention further provides methods of inducing loss of the lentiviral protein Vpr; methods of inhibiting lentivirus viral replication; and methods of treating a lentivirus infection in an individual. The methods generally involve administering to an individual infected with the lentivirus an effective amount of a compound that induces Vpr loss and/or that inhibits PPIase activity of a protein that catalyzes cis-trans isomerization of cis-peptidylprolyl bonds in Vpr.